Cheminfostream

AXLR8 2010 report on Alternative Testing Strategies

The AXLR8 2010 report on Alternative Testing Strategies is now available at:
http://axlr8.eu/axlr8-2010-progress-report.pdf

This book provides a very useful reference and comprehensive summary of all recent/current significant Alternative Testing R&D FP6/7 projects in Europe, plus additional perspectives on other initiatives e.g., in US, Japan etc. It includes a chapter on #OpenTox.

Barry

Barry Hardy PhD
Director, Community of Practice & Research Activities
and OpenTox Project Coordinator (www.opentox.org)

Advancing Collaborative Drug Discovery & Safety Infrastructure

I will deliver an OpenTox seminar at the IQPC (Pharma IQ)  Predictive Toxicology conference taking place in London 23-24 Feb 2011, in which I will present on recent developments with regards to OpenTox interoperability advances, and particularly to support of collaborative drug discovery projects.  Also of interest to the increasing support by OpenTox of in vitro methods is a significant program on stem cell technology.  The conference will address the accuracy of drug safety testing through the integration of advanced prediction methods, including stem cell based assays and screening into safety evaluation strategies. The main conference will take place in London on 23rd-24th February 2011 and new for this year, there will be a pre-conference focus day on 22nd February 2011 dedicated to the use of stem cells as a tool to enhance predictive toxicology.
http://www.predictivetoxicology.co.uk/Event.aspx?id=394530